According to the findings of our research, the genes CYBB, FCER1G, TYROBP, IL10RA, and CSF1R could represent relevant targets for the study and development of therapeutic strategies aimed at ANCA-associated vasculitis and atherosclerosis. This evidence concerns the gene TYROBP and anti-neutrophil cytoplasmic antibody-associated vasculitis.